SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001583648-19-000035
Filing Date
2019-06-18
Accepted
2019-06-18 16:05:37
Documents
5
Period of Report
2019-06-18
Effectiveness Date
2019-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A pirs2019proxystatement.htm DEF 14A 544680
2 a2019proximage1a04.jpg GRAPHIC 19022
3 a2019proximage2a04.gif GRAPHIC 2673
4 a190613proxycardpage1.jpg GRAPHIC 239554
5 a190613proxycardpage2.jpg GRAPHIC 250379
  Complete submission text file 0001583648-19-000035.txt   1250968
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37471 | Film No.: 19903733
SIC: 8731 Services-Commercial Physical & Biological Research